Logo

Publikacije (45999)

Nazad
E. Heath, Marjeta Česen, N. Negreira, M. L. Alda, L. Ferrando-Climent, L. Blahová, T. V. Nguyen, M. Adahchour et al.

Nedim Rabić, S. Heusinger, Elias H. Füllenbach, Walter Senner, Klaus-Bernward Springer

V. Nikolić, S. Janković, Z. Dimitrijevic, M. Sokolovic, B. Andrić, D. Petrovic, T. Jevtović-Stoimenov, S. Živanović et al.

S. Janković, Milica Dajić, Saša Jacović, S. Markovic, T. Papić, Tamara Petrušić, M. Radojković, A. Ranković et al.

L. Pecchia, R. Castaldo, P. Melillo, U. Bracale, M. Craven, M. Bracale

A. C. Dias, Lorana Abreu Batista, Matheus Botelho, Rosimar Caponi, É. D. Souza

The nature of performing a scientific research is a process that has several different components which consist of identifying the key research question(s), choices of scientific approach for the study and data collection, data analysis, and finally reporting on results. Generally, peer review is a series of procedures in the evaluation of a creative work or performance by other people, who work in the same or related field, with the aim of maintaining and improving the quality of work or performance in that field. The assessment of the achievement of every scientist, and thus indirectly determining his reputation in the scientific community of these publications, especially journals, is done through the so-called impact factor index. The impact factor predicts or estimates that how many annual citations article may receive after its publication. Evaluation of scientific productivity and assessment of the published articles of researchers and scientists can be made through the so-called H-index. The quality of published results of scientific work largely depends on knowledge sources that are used in the preparation, which means that it should be considered to serve the purpose and the very relevance of the information used. Scientometrics as a field of science covers all aforementioned issues, and scientometric analysis is obligatory for quality assessment of the scientific validity of published articles and other type of publications.

Ascorbic acid (AA) is a water-soluble vitamin which shows no fluorescence. However, in reaction with iron(III), AA is oxidised to dehydroascorbic acid and iron(III) is reduced to iron(II) which forms a complex with 2,4,6-tripyridyl-S-triazine (TPTZ) in buffered medium. The relative fluorescence intensity of the resulting Fe(TPTZ)22+ complex can be measured at excitation and emission wavelengths of 393 and 790 nm, respectively. Based on this data, a new indirect spectrofluorimetric method for the determination of AA in pharmaceutical samples was proposed. Influence of the reaction conditions, such as acidity of acetic buffer, concentration of TPTZ and iron(III), reaction time and instrumental parameters were investigated in detail. The linear range was from 5.4 × 10−4 to 5.4 × 10−6 mol·L−1 (R = 0.9971). The LOD was 7.7 × 10−7 mol·L−1 and LOQ was 2.3 × 10−4 mol·L−1. Fourteen pharmaceutical samples containing various amounts of AA were analysed. Influences of potential interfering substances were also examined. Analysis of commercial pharmaceutical formulations showed good correlation with the nominal values given by the manufacturers and with the results obtained by a titration method. The proposed method can be applied in routine quality control in the pharmaceutical industry due to its sensitivity, simplicity, selectivity and low cost.

Abstract The main goal of this article is to examine risk aversion impact on securities portfolio performance in underdeveloped capital markets. For the purpose of this research, portfolio performance was taken as a dependent variable, whereas investors’ attitude towards risk was considered as an independent variable. The analysis results have revealed that, ceteris paribus, an increase in risk aversion leads to a decrease in expected return and the creation of more superior securities portfolio. The article is expected to produce useful pieces of information which might be helpful for investors in the process of creating their portfolios in underdeveloped capital markets.

Nema pronađenih rezultata, molimo da izmjenite uslove pretrage i pokušate ponovo!

Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više